| Literature DB >> 27233777 |
Kazuko Mitoku1, Naoko Masaki2, Yukiko Ogata3, Kazushi Okamoto4.
Abstract
BACKGROUND: Vision and hearing impairments among elders are common, and cognitive impairment is a concern. This study assessed the association of vision and hearing impairments with cognitive impairment and mortality among long-term care recipients.Entities:
Keywords: Cognitive impairment; Death; Elders; Hearing impairment; Visual impairment
Mesh:
Year: 2016 PMID: 27233777 PMCID: PMC4884419 DOI: 10.1186/s12877-016-0286-2
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Participant characteristics
| Men | Women | Total |
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| % |
| % |
| % | |||||
| Total | 605 | 100.0 | 1149 | 100.0 | 1754 | 100.0 | ||||
| Mean age (SD) (years) | 80.89 (7.39) | 82.42 (6.95) | < .001 | f | ||||||
| Age group (years) | 65–74 | 127 | 21.0 | 160 | 13.9 | 287 | 16.4 | < .001 | e | |
| 75–89 | 400 | 66.1 | 789 | 68.7 | 1189 | 67.8 | ||||
| ≥90 | 78 | 12.9 | 200 | 17.4 | 278 | 15.8 | ||||
| Level of dependencya | Low | 341 | 56.4 | 774 | 67.4 | 1115 | 63.6 | < .001 | c | |
| Medium | 264 | 43.6 | 375 | 32.6 | 639 | 36.4 | ||||
| Functional assessmentb | Cognitive impairment | 319 | 52.7 | 631 | 54.9 | 950 | 54.2 | .382 | c | |
| Comorbidity (ICD10) | Diabetes | 50 | 8.3 | 96 | 8.4 | 146 | 8.3 | .513 | ||
| Neurological disorders (except Alzheimer’s disease) | 57 | 9.4 | 80 | 7.0 | 137 | 7.8 | .043 | c | ||
| Hypertension | 104 | 17.2 | 286 | 24.9 | 390 | 22.2 | .294 | |||
| Heart disease | 50 | 8.3 | 60 | 5.2 | 390 | 6.3 | .009 | |||
| Cerebrovascular disease | 200 | 33.1 | 204 | 17.8 | 404 | 23.0 | < .001 | |||
| Respiratory disease | 64 | 10.6 | 61 | 5.3 | 125 | 7.1 | < .001 | |||
| Musculoskeletal connective tissue disorder | 153 | 25.3 | 524 | 45.6 | 677 | 38.6 | < .001 | |||
| Eye disease | 11 | 1.8 | 27 | 2.3 | 38 | 2.2 | .294 | d | ||
| Ear disease | 7 | 1.2 | 14 | 1.2 | 21 | 1.2 | .556 | |||
| Dementia | 100 | 16.5 | 274 | 23.8 | 374 | 21.3 | < .001 | c | ||
aLevel of dependency (long-term care insurance)
bFunctional assessment for cognitively impaired elders (long-term care insurance)
c χ 2 test
dFisher’s exact test
eMann-Whitney U test
f t test
Prevalence of vision/hearing impairment
| Men | Women | Total | |||||
|---|---|---|---|---|---|---|---|
|
| % |
| % |
| % | ||
| Total | 605 | 100.0 | 1149 | 100.0 | 1754 | 100.0 | |
| Vision/hearing functions | Normal vision/hearing function | 252 | 41.7 | 521 | 45.3 | 773 | 44.1 |
| Vision impairment | 79 | 13.1 | 173 | 15.1 | 252 | 14.4 | |
| Hearing impairment | 159 | 26.3 | 250 | 21.8 | 409 | 23.3 | |
| Dual sensory impairment | 115 | 19.0 | 205 | 17.8 | 320 | 18.2 | |
Vision/hearing impairment and cognitive decline by age group
| Total | Cognitive decline | OR | Univariate analysis |
| OR | Multivariate analysis |
| |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95 % CI | 95 % CI | |||||||||||
| Lower limit | Upper limit | Lower limit | Upper limit | |||||||||
| Overall | Normal vision/hearing function | 773 | 360 | 1.000 | - | - | - | 1.000 | - | - | - | a |
| Vision impairment | 252 | 138 | 1.389 | 1.04 | 1.85 | 0.02 | 1.457 | 1.07 | 0.02 | |||
| Hearing impairment | 409 | 237 | 1.581 | 1.24 | 2.01 | <0.001 | 1.473 | 0.00 | ||||
| Dual sensory impairment | 320 | 215 | 2.349 | 1.79 | 3.09 | <0.001 | 1.965 | <0.001 | ||||
| Total | 1754 | 950 | ||||||||||
| 65–74 (yrs) | Normal vision/hearing function | 185 | 61 | 1.000 | - | - | - | 1.000 | - | - | - | b |
| Vision impairment | 59 | 27 | 1.715 | 0.94 | 3.12 | 0.08 | 1.774 | 0.89 | 3.54 | 0.10 | ||
| Hearing impairment | 27 | 10 | 1.196 | 0.52 | 2.77 | 0.68 | 1.246 | 0.49 | 3.19 | 0.65 | ||
| Dual sensory impairment | 16 | 9 | 2.614 | 0.93 | 7.35 | 0.07 | 2.653 | 0.78 | 8.99 | 0.12 | ||
| Total | 287 | 107 | ||||||||||
| 75–85 | Normal vision/hearing function | 518 | 258 | 1.000 | - | - | - | 1.000 | - | - | - | b |
| Vision impairment | 172 | 99 | 1.367 | 0.97 | 1.94 | 0.08 | 1.513 | 1.04 | 2.21 | 0.03 | ||
| Hearing impairment | 281 | 164 | 1.413 | 1.05 | 1.89 | 0.02 | 1.584 | 1.15 | 2.18 | 0.00 | ||
| Dual sensory impairment | 218 | 147 | 2.086 | 1.50 | 2.91 | <0.001 | 1.916 | 1.34 | 2.74 | <0.001 | ||
| Total | 1189 | 668 | ||||||||||
| ≥90 | Normal vision/hearing function | 70 | 41 | 1.000 | - | - | - | 1.000 | - | - | - | b |
| Vision impairment | 21 | 12 | 0.943 | 0.35 | 2.53 | 0.91 | 0.976 | 0.32 | 2.99 | 0.97 | ||
| Hearing impairment | 101 | 63 | 1.173 | 0.63 | 2.19 | 0.62 | 1.222 | 0.60 | 2.49 | 0.58 | ||
| Dual sensory impairment | 86 | 59 | 1.546 | 0.80 | 2.99 | 0.19 | 1.437 | 0.68 | 3.04 | 0.34 | ||
| Total | 278 | 175 | ||||||||||
aAdjusted for age, sex, level of dependency, diabetes, neurological disease, hypertension, heart disease, cerebrovascular disease, respiratory disease, musculoskeletal and connective tissue disorders, and eye and ear diseases
bAdjusted for the above variables except age
Vision/hearing impairment, cognitive decline and mortality by age group
| Cognitive decline | Participants | Univariate analysis | Multivariate analysis | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95 % CI | HR | 95 % CI |
| HR | 95 % CI |
| ||||||||
| Total | Death | Movers | Lower limit | Upper limit | Lower limit | Upper limit | ||||||||
| Overall | Normal vision/hearing function | No | 413 | 155 | 11 | 1.00 | - | - | - | 1.000 | - | - | - | a |
| Yes | 360 | 184 | 9 | 1.496 | 1.21 | 1.85 | 0.00 | 1.138 | 0.91 | 1.42 | 0.25 | |||
| Vision impairment | No | 114 | 46 | 2 | 1.060 | 0.76 | 1.47 | 0.73 | 1.043 | 0.74 | 1.46 | 0.81 | ||
| Yes | 138 | 60 | 2 | 1.096 | 0.81 | 1.48 | 0.55 | 0.875 | 0.65 | 1.19 | 0.39 | |||
| Hearing impairment | No | 172 | 90 | 4 | 1.614 | 1.24 | 2.09 | 0.00 | 1.154 | 0.88 | 1.51 | 0.30 | ||
| Yes | 237 | 138 | 9 | 1.889 | 1.50 | 2.38 | 0.00 | 1.225 | 0.96 | 1.56 | 0.10 | |||
| Dual sensory impairment | No | 105 | 58 | 3 | 1.644 | 1.22 | 2.22 | 0.00 | 1.106 | 0.81 | 1.51 | 0.52 | ||
| Yes | 215 | 133 | 8 | 1.980 | 1.57 | 2.50 | 0.00 | 1.290 | 1.01 | 1.65 | 0.04 | |||
| Total | 1754 | 864 | 48 | |||||||||||
aAdjusted for age, sex, level of dependency, diabetes, neurological disease, hypertension, heart disease, cerebrovascular disease, respiratory disease, musculoskeletal and connective tissue disorders, and eye and ear diseases